Prevalence of pulmonary hypertension in systemic sclerosis and it s correlation with clinical variables
|
|
- Russell Carson
- 5 years ago
- Views:
Transcription
1 IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: , p-issn: Volume 16, Issue 9 Ver. X (September. 2017), PP Prevalence of pulmonary hypertension in systemic sclerosis and it s correlation with clinical variables DR. Bhuban Majhi 1, * DR. Nandita Pal 2 1 Assistant Professor, Department of Cardiology, ICVS, IPGME&R, Kolkata-20 2 Assistant Professor, Department of Microbiology, College of Medicine & Sagore Dutta Hospital, Kamarhati, Kolkata-58 Corresponding author: *DR. Nandita Pal Abstract Introduction: Development of pulmonary artery hypertension (PAH) worsens prognosis of systemic sclerosis (SSc) and can be either isolated precapillary PAH or secondary to interstitial lung disease (ILD). Early diagnosis is of crucial importance. There is scarcity of data on PAH in patients with SSc in India. Objectives: To determine the prevalence and clinical correlates of PAH in systemic sclerosis using noninvasive cardiopulmonary evaluation and in selected cases by cardiac catheterization. Materials And Methods: Clinical and functional characteristics of 100 patients of systemic sclerosis were studied and they were evaluated by echocardiography to detect pulmonary artery hypertension. Our objective was to study the prevalence and the clinical correlation of PAH in SSc Results: PAH was found in 29% patients on echocardiography. Prevalence tend to increase with age of onset and duration of disease. However, it did not differ significantly between patients with limited cutaneous SSc (lcssc) and patients with diffuse cutaneous SSc (dcssc). On binary logistic regression analysis, none of the studied variables had any independent influence on development of PAH. Conclusion: PAH in SSc occurs in a remarkable proportion (29%) of patients without any ominous signs in early stages. Non-invasive screening of patients with SSc for PAH will help in early diagnosis and appropriate timely therapeutic intervention before significant end-organ damage occurs. Keywords: Interstitial lung disease, pulmonary artery hypertension, Raynaud s phenomenon, systemic sclerosis Date of Submission: Date of acceptance: I. Introduction Scleroderma or systemic sclerosis is a generalized connective tissue disorder characterized by microvascular obliteration & increased deposition of collagen, resulting in widespread fibrotic lesions. 1,2 SSc involves not only the skin but a host of other organ systems. Cardio Pulmonary involvement is a common feature of systemic sclerosis and one of the principle causes of death in such patients. 3 Cardiovascular disease in patients with SSc may be due to either primary involvement of the heart by sclerosing disease or a secondary involvement from disease of the kidney or lungs. Cardiac involvement is a poor prognostic factor & PAH itself is a sole ominous prognostic sign in SSc. Various risk factors like increasing age, male gender, digital pits, infarcts and black race have been implicated in the development of pulmonary arterial hypertension in scleroderma. 4 Therefore, resort to all available diagnostic procedures is recommended to achieve an early diagnosis II. Materials And Methods The concerned non randomized crosssectional observational study (without any control) was conducted from January 2010 to June 2012 on 100 patients, presenting with clinical & laboratory evidences of SSc at departments of Rheumatology, General Medicine and Cardiology, at an apex institute in Kolkata, India after prior ethical clearance. Inclusion criteria were based on presence of symmetric sclerosis according to American College of Rheumatology (ACR) criteria. 5 Informed consent was taken from all study subjects. Pregnant females and patients with acute left ventricular failure, valvular heart disease involving mitral valve, atrial fibrillation, chronic liver disease with portal hypertension with porto-pulmonary shunt were carefully excluded from the study. Subjects were clinically evaluated for involvement of musculoskeletal and other organ systems in a case record format. Immunologic markers studied included: ANA (anti nuclear antibody), ENA (extractable DOI: / Page
2 nuclear antibody) Panels. Chest X-ray PA view & 12 lead ECG and HRCT-thorax in selected cases. Echocardiography (2D, M-Mode and color Doppler) were evaluated in all the cases. Confirmation of PAH in borderline cases was done by right heart catheterization & showing a mean pulmonary artery pressure >25 mm of Hg during rest &>30 mm Hg during exercise. Methods of estimating pulmonary artery pressure were based on American Society of Echocardiography guidelines. Estimated pulmonary artery systolic pressure more than 40 mmhg by echocardiography, or, peak tricuspid regurgitation (TR) gradient more than 35mmHg, or, estimated mean pulmonary artery pressure (MPAP) more than 25 mmhg was defined as pulmonary arterial hypertension. Pulmonary artery pressure was compared among different demographic variables and correlations with clinical parameters were studied. Compared disease sub-groups were: DcSSc, LcSSc, CREST syndrome and overlap syndrome. Statistical analysis was done using SPSS16 software. Chi-square test and Fischer s exact test was used for dependent categorical variables. For dependent interval and normal variables between multiple independent groups ANOVA test was used to find out level of significance. Correlation coefficient was calculated for interval and normal variables to find out degree of correlation. Binary logistic regression analysis was done to find out any independent predictors of PAH. III. Results 100 patients were studied, which included 92 females & 8 males (Table 1). Most (74%) of the patients belonged to the age group of Among 100 patients 66 had a rural background and 34 patients belonged to urban area. There was no statistically significant difference of locality among the different disease groups (P>0.5). 66 patients came from lower socioeconomic strata, 34 were from middle income group and none belonged to the higher socioeconomic strata. Among the 100 patients of SSc, 78 had DcSSc and 18 had LcSSc including CREST variant and rest of the 4 patients had overlap syndrome. Mean duration of disease in the total population was 4.84 ± 2.55 years. There was no statistically significant difference of mean duration of disease between different disease groups (P =0.68). Maximum duration of disease was 16 years and minimum duration of disease was 6 months. The most common skin finding was hyperpigmentation which was strikingly high (95%) with predominant diffuse (69%), followed by mottled type (29%). Calcinosis, telengiectasia and digital ulcer was found in 50%, 46% and 48% cases respectively. All of them were found significantly higher in the LcSSc, CREST and overlap syndrome compared to DcSSc group (P<.01). 31% of the patient having digital ulcers developed PAH. Table- 1: Demographic profile and clinical features of study population Variables Our data Mean age of disease presentation 34.99yrs % of females 92(92%) Reynaud s Phenomenon 92(92%) Hyperpigmentation 95(95%) Skin thickening 100(100%) Digital pits/ulcers 48(48%) ANA 90(90%) Dyspnea 42(42%) PAH 29(29%) ILD 37(37%) # Mean PASP 33.5± 11.01mmHg $ Mean MPAP ± 7.21mm Hg # mean pulmonary artery systolic pressure, $population mean of mean pulmonary artery pressure 10 patients had borderline pulmonary artery pressure in echocardiography. They underwent right heart catheterization after proper consent. MPAP more than 25 mmhg at resting condition was confirmed in 5 of these patients. In the other five patients PAH was excluded. Mean pulmonary pressure in the patients who underwent right heart catheterization was mmhg. There was a weak correlation (ρ = ) between between sex of patients and PHTN. It was not statistically significant (P = 0.225). No significant correlation was found between age of patients, duration of disease in years, skin score, duration of Raynaud s phenomenon in months and mean as well as systolic pulmonary arterial pressure. On binary logistic regression analysis none of the variables like age of the patient, duration of disease in years, duration of Raynaud s in months, disease subtype, skin score, presence of calcinosis, or telangiectasia were found to have any independent predictive effect for the development of PAH. However significant correlation was found between right ventricular internal diameter in diastole and pulmonary artery systolic pressure (ρ = 0.23, P =.036). Significant negative correlation was also found between ejection fraction and right ventricular diastolic dimension (ρ = and P =.002).Systolic and mean pulmonary artery pressure in different patient groups has been shown in Table2. DOI: / Page
3 Table-2: Systolic and mean pulmonary artery pressure in different patient groups. (mmhg) Groups SSc DcSSc LcSSc CREST Overlap Male Female MPAP Mean 20.54± 20.09± 22.87± 20.68± 22.30± 23.46± 20.19± St.DEV SPAP Mean 33.46± 33.13± 38.38± ± 32.48± 38.92± 32.99± St.DEV Figure 1: Grading of PAH in SSc patients PAH was detected in 29 patients. Among them, 24 patients had mild PAH (MPAP mmhg) while 4 patients had moderate PAH (MPAP 35-50mmHg) and one patient had severe PAH (MPAP >50mmHg) [Figure 1]. Age wise presentation of PAH has been shown in Figure 2. Figure 2: Bar diagram showing Age wise presentation of PAH in the study population There was increased incidence of PAH among 60-69yr age group compared to other groups, but overall it didn t reach statistical significance (P=0.49). However, year age group had significantly higher DOI: / Page
4 mean pulmonary artery pressure compared to 10-19,20-29,30-39, age groups (P< 0.01) and year age group (P< 0.05). About 27.2% of females and 50% of males had pulmonary artery hypertension. There was no significant difference between the two groups in the incidence of PAH, (P = 0.225). Percentage of PAH in different disease groups were: SSc (29%), DcSSc (29.5%), LcSSc (26.7%), CREST (33.3%), Overlap syndrome (25%). ANA staining pattern and their relationship with presence of PAH is shown in Table3. It was statistically significant (P = 0.048). Table-3: ANA pattern and pulmonary hypertension cross-tabulation ANA patterns PAH Absent (no. of patients) PAH Present (no. of patients) Total Absent Speckle Nucleolar Mixed Homogenous Total The most common pattern observed was speckled (56%), followed by nucleolar (25%) and mixed (speckled/nucleolar, homogenous/nucleolar) (9%). Correlation between disease type and presence of types of ENA was good. AntiScl-70 was found mainly in the diffuse cutaneous scleroderma group whereas LcSSc&CREST group had mainly anti-centromere antibodies. Anti U1rnp was found significantly more in the overlap syndrome patients (P<.0001).Relationship of ENA (extractable nuclear antibody) with presence of PAH is shown in Table-4. Table-4: ENA pattern and pulmonary hypertension cross-tabulation ENA PAH Absent PAH Present Total (no. of patients) (no. of patients) No ENA Anti Scl-70 ab Anticentromere ab AntiU1RNP ab Total However, PAH was not influenced significantly by the presence or absence of ENA or by the type of ENA (P = 0.372). ILD was present in 37 patients. Relationship of ILD & PAH is shown in Table 5. Status of ILD Table- 5: Presence of ILD & PAH cross-tabulation PAH Absent PAH Present (no. of patients) (no. of patients) DOI: / Page Total ILD absent ILD present Total ILD was present in 37 patients (37%) out of 100 patients studied. Those without ILD, 21cases (33.3%) had pulmonary arterial hypertension. 8(21.6%) patients with ILD also had pulmonary artery hypertension. This difference was not statistically significant between the two groups (P = 0.3). IV. Discussion Our study population had more diffuse cutaneous (78%) and less of limited cutaneous scleroderma (18%) variant compared to previous studies both in India and Western world. 6 Mean age of presentation of 34.99± years was similar to other Indian studies and lower than the Western literature. 6,7 There was female preponderance in our study (92/8) similar to other Western studies Maione S et al. 8 Mean duration of disease (4.84±2.55years) was much less in our study compared to previous studies by Mukherjee et al, Meune et al, and Maione S et al but nearly similar to other studies. 7,8,9,10 Most common non respiratory symptom, was Raynaud s phenomenon present in 92% of cases similar to the western literature and most of the Indian
5 literature except for one South Indian study where it was reported to be Skin pigmentation in our study population was similar to one study from India and another from Iraq % of cases of the patient having digital ulcers developed PAH similar to other studies. 13 ANA was found positive in 90% of patients almost similar in frequency between the different disease subsets. This result is at par with the results found in previous studies in India but higher than Western studies. 14,15 Higher incidence of nucleolar pattern than our study was observed by another Indian study. 7 Pulmonary artery hypertension (PASP 40mmHg or MPAP 25mmHg) was found in 29 % of cases. Estimates of the prevalence of scleroderma-associated PAH vary widely in the past literature depending on the definition of PAH used and the diagnostic tools used to identify PAH. Using echocardiography as a diagnostic tool, up to 60% of scleroderma patients have been reported to have PAH. However, using cardiac catheterization as a diagnostic tool to confirm the presence of PAH, a much lower prevalence rate in the range of 8%-12% has been reported. Lower prevalence of PAH was partly due to higher cut off value in our study. However, when 30 mmhg was taken as cut off value the prevalence increased to 56%. Mean pulmonary artery systolic pressure in our study population was33.52± The cut off value of 35mm Hg for trans tricuspid pressure gradient which we used has sensitivity of 75%, specificity of 66% and positive and negative predictive value of 85% and 50% respectively. 16 Our study more or less confirms the finding of Kumar U et al. 17 In our study, prevalence of PAH didn t differ significantly between those with clinically detectable ILD (37 patients) and without ILD. This suggests poor sensitivity of clinical examination in ILD. Probability of subclinical ILD in the rest of the patients probably has accounted for this result. Incidence of ILD was slightly lower in our study patients compared to other studies probably because HRCT thorax couldn t be done in all cases. However, the finding was similar to that of Gaude G S et al. 18 Strengths of our study were: (1) relatively good sample size, (2) heterogeneity of population, (3) detailed echocardiography examination, (4) Tissue Doppler examination in all cases. However, limitations of the study were: i) relatively smaller number of LcSSc cases, ii) not confirming PAH in all cases by right heart catheterization, iii) not determining severity of DLPD by HRCT fibrosis score or doing DLCO, (iv) lack of prospective follow up of echocardiographic data. V. Conclusion Systemic sclerosis involves a multitude of organs with a plethora of complications. Development of pulmonary hypertension is of immense prognostic consequence. However, at the early stages overt clinical features may be absent. Hence early detection of complications is an utmost necessity to relieve patient s sufferings. Noninvasive assessment of PAH in SSc patients enable us to institute early therapeutic intervention to prevent clinical deterioration. Prospective follow up of such patients may confer better understanding of the influence of clinical and demographic variables over the course of disease, behavior of pulmonary artery hypertension over time and its clinical outcome. Better understanding of this dreaded disease and its ominous consequences might assist in the research and development of newer therapies to reduce patient sufferings and to increase their longevity. VI. Bibliography [1]. Rodnan GP, Lipinski E, Lucksick J. Skin thickness & collagen content in progressive systemic sclerosis & localized scleroderma. Arthritis Rheum. 1979;22(2): [2]. LeRoy EC. A brief overview of pathogenesis of scleroderma. Ann Rheum Dis. 1992;51 : [3]. Fauci Al. Harrisons Principle of Internal Medicine. Mc-Graw- Hill. 17 th Ed [4]. Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in scleroderma. Chest.2003;124: [5]. Subcommittee for Scleroderma Criteria of the ARA Diagnostic & Therapeutic Criteria Committee.Prliminary criteria for classification of systemic sclerosis. Arthritis Rhoum.1980;23: [6]. Clements PJ, Roth MD, Elashoff R, Tashkin DP, Goldin J, Silver RM, Sterz M, Seibold JR, Schraufnagel D, Simms RW, Bolster M. Scleroderma lung study( SLS): differences in presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007;66(12): [7]. Sharma VK, Trilokraj T, Khaitan BK, Krishna SM. Profile of systemic sclerosis in a tertiary care center in North India. Profile of systemic sclerosis in tertiary care centre in North India. Indian J DermatolVenerolLeprol. 2006;72(6): [8]. Maione S, Cuomo G, Giunta A, de Horatio LT, La Montagna G, Manguso F, Alagia I, Valentini G. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Sem in Arthritis Rheum. 2005;34(5): [9]. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of registry approach. Ann Rheum Di.s 2003;62(11): [10]. Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, Guillevin L, Kahan A, Allanore Y. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58(6): [11]. Krishnamurthy V, Porkodi R, Ramakrishnan S, et al. Progressive systemic sclerosis in south India. J Assoc Physics India.1991;39: [12]. Al-Adhadh RN, A-Sayed TA. Clinical Features of Systemic Sclerosis. Saudi Med J.2001;22: DOI: / Page
6 [13]..Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Moinzadeh P, Müller-Ladner U, Pfeiffer C, Riemekasten G, Schulze-Lohoff E. The registry of the German Network of Systemic Sclroderma: frequency of disease subsets and patterns of organ involvement. Rheumatol. 2008;47(8): [14]. Kumar A, Malaviya AN, Tiwari SC, Singh RR, Pande JN. Clinical and Laboratory profile of systemic sclerosis in northern India. J Assoc Physics India. 1990;38(10): [15]. Medsger TA, Masi AT. The epidemiology of systemic sclerosis (scleroderma). Ann Intern Med.1971;74: [16]. Denton CP, Black CA. Pulmonary hypertension in systemic sclerosis. Rheum Dis Clin North Am. 2003;29(2): [17]. Kumar U, Ramteke R, Yadav R, Ramam M, Handa R, Kumar A. Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis. J Assoc Phys India. 2008;56: [18]. Gaude G S, Mahishale V, srivastava A. Pulmonary Manifestations in Connective Tissue Disorders:Hospital-based Study at a Tertiary Care Hospital. The Indian Journal of Chest Diseases & Allied Sciences. 2009;51: *DR. Nandita Pal. "Prevalence of pulmonary hypertension in systemic sclerosis and it s correlation with clinical variables." IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 16.9 (2017): DOI: / Page
different phenotypes
Pulmonary hypertension in scleroderma: different phenotypes UMR 995 Pr David LAUNAY, MD, PhD launayd@gmail.com Service de Médecine Interne. Unité d'immunologie Clinique CNRMR Maladies Systémiques et Autoimmunes
More informationPredictors of Isolated Pulmonary Hypertension in Patients With Systemic Sclerosis and Limited Cutaneous Involvement
ARTHRITIS & RHEUMATISM Vol. 48, No. 2, February 2003, pp 516 522 DOI 10.1002/art.10775 2003, American College of Rheumatology Predictors of Isolated Pulmonary Hypertension in Patients With Systemic Sclerosis
More informationPrevalence and Predictors of Pulmonary Artery Hypertension in Systemic Sclerosis
Original Article# Prevalence and Predictors of Pulmonary Artery Hypertension in Systemic Sclerosis Uma Kumar*, R Ramteke+, R Yadav++, M Ramam+++, Rohini Handa**, A Kumar** Abstract Introduction : Development
More informationNailfold Capillary Density is Associated with the Presence and Severity of Pulmonary Arterial Hypertension in Systemic Sclerosis
4 Nailfold Capillary Density is Associated with the Presence and Severity of Pulmonary Arterial Hypertension in Systemic Sclerosis Herman M.A. Hofstee, Anton Vonk Noordegraaf, Alexandre e. Voskuyl, Ben
More informationSCLERODERMA 101. Maureen D. Mayes, MD, MPH Professor of Medicine University of Texas - Houston
SCLERODERMA 101 Maureen D. Mayes, MD, MPH Professor of Medicine University of Texas - Houston TYPES OF SCLERODERMA Localized versus Systemic Two Kinds of Scleroderma Localized Scleroderma Morphea Linear
More informationImproving the Detection of Pulmonary Hypertension in Systemic Sclerosis Using Pulmonary Function Tests
ARTHRITIS & RHEUMATISM Vol. 63, No. 11, November 2011, pp 3531 3539 DOI 10.1002/art.30535 2011, American College of Rheumatology Improving the Detection of Pulmonary Hypertension in Systemic Sclerosis
More informationClinical Investigations
Clinical Investigations Right Ventricular Systolic Pressure Assessed by Echocardiography: A Predictive Factor of Mortality in Patients With Scleroderma Address for correspondence: Songsak Kiatchoosakun,
More informationScholars Journal of Medical Case Reports
Scholars Journal of Medical Case Reports Sch J Med Case Rep 2015; 3(9B):928-932 Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and Scientific Resources)
More informationSTUDY OF PULMONARY ARTERIAL HYPERTENSION IN RESPIRATORY DISORDERS
STUDY OF PULMONARY ARTERIAL HYPERTENSION IN RESPIRATORY DISORDERS *Hegde R.R., Bharambe R.S., Phadtare J.M. and Ramraje N.N. Department of Pulmonary Medicine, Grant Government Medical College, Mumbai-8
More informationThe frequency of pulmonary hypertension in patients with juvenile scleroderma
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES RESEARCH ARTICLE WWW.BJBMS.ORG The frequency of pulmonary hypertension in patients with juvenile scleroderma Amra Adrovic 1, Funda Oztunc 2, Kenan Barut 1, Aida
More informationNOT COPY. Choice of the primary outcome: Pro Lung 03/09/2018. Lung assessment in clinical trials
Choice of the primary outcome: Pro Lung Christopher P. Denton Professor of Experimental Rheumatology Royal Free Hospital and University College London, UK Florence 7 th September 218 Improved clinical
More informationDisclosures. Scleroderma: Early Diagnosis How early is early? 10/28/2013. Difficult Scleroderma: How do I Approach this Patient?
Disclosures Financial support: None Difficult Scleroderma: How do I Approach this Patient? Francesco Boin, MD Assistant Professor of Medicine Director, Translational Research Johns Hopkins Scleroderma
More informationEchocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis
Rheumatology Advance Access published January 6, 2004 Rheumatology 2004; 1 of 6 Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis D. Mukerjee,
More informationRelation of Novel Echocardiographic Measures to Invasive Hemodynamic Assessment in Scleroderma-Associated Pulmonary Arterial Hypertension
Arthritis Care & Research Vol. 66, No. 9, September 2014, pp 1386 1394 DOI 10.1002/acr.22307 2014, American College of Rheumatology ORIGINAL ARTICLE Relation of Novel Echocardiographic Measures to Invasive
More informationPeripheral (digital) vasculopathy in systemic. sclerosis. Ariane Herrick
Peripheral (digital) vasculopathy in systemic sclerosis Ariane Herrick Raynaud s phenomenon VASOPASM DEOXYGENATION REPERFUSION Main causes of RP Primary (idiopathic) Connective tissue diseases, including
More informationPrevalence and Predictors of Pulmonary Arterial Hypertension in a Sample of Iraqi Patients with Systemic Sclerosis: A Cross-Sectional Study
Prevalence and Predictors of Pulmonary Arterial Hypertension in a Sample of Iraqi Patients with Systemic Sclerosis: A Cross-Sectional Study Ziad S.Al-Rawi 1, Faiq I.Gorial 1*, Ahmed S. Al-Naaimi 2, Ahmed
More informationWhat is controversial in diagnostic imaging?
Controversies in the management of pulmonary hypertension What is controversial in diagnostic imaging? G. Derumeaux Lyon University Hospices Civils de Lyon France Déclaration de Relations Professionnelles
More informationEchocardiographic and Doppler Assessment of Cardiac Functions in Patients of Non-Insulin Dependent Diabetes Mellitus
ORIGINAL ARTICLE JIACM 2002; 3(2): 164-8 Echocardiographic and Doppler Assessment of Cardiac Functions in Patients of Non-Insulin Dependent Diabetes Mellitus Rajesh Rajput*, Jagdish**, SB Siwach***, A
More informationEchocardiographic study of left ventricular diastolic dysfunction in normotensive asymptomatic type II diabetes mellitus
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 7 Ver. VI (July. 2015), PP 39-43 www.iosrjournals.org Echocardiographic study of left ventricular
More informationCTD-related Lung Disease
13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of
More informationSCLERODERMA: An Update. What You Need To Know
SCLERODERMA: An Update What You Need To Know Pre Test Question #1 The onset of systemic sclerosis is typically: A. In the 1st decade of life B. Between the 4th and 6th decade C. Equal in all age groups
More informationEcho in Systemic Disease
Echo in Systemic Disease Vera H. Rigolin, MD, FASE, FACC, FAHA Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern Memorial
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091593 Age 25 Years Gender Male 30/8/2017 91600AM 30/8/2017 93946AM 31/8/2017 84826AM Ref By Final COLLAGEN DISEASES ANTIBODY ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF),
More informationTest Name Results Units Bio. Ref. Interval
135091660 Age 44 Years Gender Male 29/8/2017 120000AM 29/8/2017 100219AM 29/8/2017 105510AM Ref By Final EXTRACTABLENUCLEAR ANTIGENS (ENA), QUANTITATIVE ROFILE CENTROMERE ANTIBODY, SERUM 20-30 Weak ositive
More informationPulmonary Hypertension: Echocardiographic Evaluation of Pulmonary Hypertension and Right Ventricular Function. Irmina Gradus-Pizlo, MD
Pulmonary Hypertension: Echocardiographic Evaluation of Pulmonary Hypertension and Right Ventricular Function Irmina Gradus-Pizlo, MD Disclosures: Nothing to disclose Overview Is pulmonary hypertension
More informationCardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients
1 Department of Cardiovascular Radiology, Regional University Hospital, Lille 2 University, Lille, France; 2 Department of Internal Medicine, National Reference Centre for Systemic and Autoimmune Rare
More informationWhat will we discuss today?
Autoimmune diseases What will we discuss today? Introduction to autoimmune diseases Some examples Introduction to autoimmune diseases Chronic Sometimes relapsing Progressive damage Epitope spreading more
More informationMethodology used to develop new ACR-EULAR criteria. Disclosures. Objectives Guiding principles underlying methodology
Methodology used to develop new ACR-EULAR criteria Sindhu Johnson MD PhD Toronto Scleroderma Program University of Toronto Co-convenors Janet Pope Frank van den Hoogen Members Jaap Fransen Sindhu Johnson
More information9/15/11. Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September Scleroderma. Hard skin
Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September 2011 Scleroderma Hard skin 1 No diagnostic test for scleroderma Pathogenesis is unknown prominent features of disease reflect
More informationBiomarkers of pulmonary hypertension in patients with scleroderma: a case control study
McMahan et al. Arthritis Research & Therapy (2015) 17:201 DOI 10.1186/s13075-015-0712-4 RESEARCH ARTICLE Open Access Biomarkers of pulmonary hypertension in patients with scleroderma: a case control study
More informationUpdate in Systemic Sclerosis! Lauren Kim MD! NW Rheumatology Associates
Update in Systemic Sclerosis! Lauren Kim MD! NW Rheumatology Associates Review Systemic sclerosis affects approximately 75,000 to 100,000 people in the U.S. and has the highest mortality rate of any autoimmune
More informationA study of left ventricular dysfunction and hypertrophy by various diagnostic modalities in normotensive type 2 diabetes mellitus patients
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 8:102-106 A study of left ventricular dysfunction and hypertrophy by various
More informationPulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
More informationPrevalence of pulmonary hypertension in systemic sclerosis
Prevalence of pulmonary hypertension in systemic sclerosis A.B. Cordeiro de Azevedo 1,4, P.D. Sampaio-Barros 3,4, R. Moraes Torres 2, C. Moreira 1 1 Unit of Rheumatology and 2 Sector of Echocardiography,
More informationA Comparison Between Anti-Th/To and Anticentromere Antibody Positive Systemic Sclerosis Patients With Limited Cutaneous Involvement
ARTHRITIS & RHEUMATISM Vol. 48, No. 1, January 2003, pp 203 209 DOI 10.1002/art.10760 2003, American College of Rheumatology A Comparison Between and Anticentromere Antibody Positive Systemic Sclerosis
More informationSEVERE ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS WITH DIFFUSE SCLERODERMA
ARTHRITIS & RHEUMATISM Vol. 43, No. 11, November 2000, pp 2437 2444 2000, American College of Rheumatology 2437 SEVERE ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS WITH DIFFUSE SCLERODERMA VIRGINIA D. STEEN
More informationA STUDY OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSION Ravi Keerthy M 1
A STUDY OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSION Ravi Keerthy M 1 HOW TO CITE THIS ARTICLE: Ravi Keerthy M. A Study of Left Ventricular Diastolic Dysfunction in Hypertension. Journal of
More informationEvaluation of American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the FaSScinate Trial
Evaluation of American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the FaSScinate Trial D Khanna 1, V Berrocal 1, C Denton 2, A Jahreis 3, H Spotswood
More informationU ntil recently, pulmonary arterial hypertension (PAH) in
1088 EXTENDED REPORT Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach D Mukerjee, D St George, B Coleiro, C Knight, C P Denton,
More informationRight Heart Hemodynamics: Echo-Cath Discrepancies
Department of cardiac, thoracic and vascular sciences University of Padua, School of Medicine Padua, Italy Right Heart Hemodynamics: Echo-Cath Discrepancies Luigi P. Badano, MD, PhD, FESC, FACC **Dr. Badano
More informationRight Heart Catheterization. Franz R. Eberli MD Chief of Cardiology Stadtspital Triemli, Zurich
Right Heart Catheterization Franz R. Eberli MD Chief of Cardiology Stadtspital Triemli, Zurich Right Heart Catheterization Pressure measurements Oxygen saturation measurements Cardiac output, Vascular
More informationClinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey
Interatrial Block and P-Terminal Force: A Reflection of Mitral Stenosis Severity on Electrocardiography Murat Yuce 1, Vedat Davutoglu 1, Cayan Akkoyun 1, Nese Kizilkan 2, Suleyman Ercan 1, Murat Akcay
More informationDOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES
THORAXCENTRE DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES J. Roelandt DOPPLER HEMODYNAMICS Intracardiac pressures and pressure gradients Volumetric measurement
More informationLung function abnormalities and decline of spirometry in scleroderma: an overrated danger?
Postgrad Med J (1991) 67, 632-637 i) The Fellowship of Postgraduate Medicine, 1991 Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger? M.J. Abramson, A.J. Barnett',
More informationPULMONARY HYPERTENSION
PULMONARY HYPERTENSION REVIEW & UPDATE Olga M. Fortenko, M.D. Pulmonary & Critical Care Medicine Pulmonary Vascular Diseases Sequoia Hospital 650-216-9000 Olga.Fortenko@dignityhealth.org Disclosures None
More informationEcho Doppler Assessment of Right and Left Ventricular Hemodynamics.
Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP Northwell, Lenox Hill Hospital, New York Professor of Cardiology Hofstra University
More informationMyositis and Your Lungs
Myositis and Your Lungs 2013 TMA Annual Patient Meeting Louisville, Kentucky Chester V. Oddis, MD University of Pittsburgh Director, Myositis Center Myositis Heterogeneous group of autoimmune syndromes
More informationConnective tissue disease related Pulmonary arterial hypertension
Connective tissue disease related Pulmonary arterial hypertension DM Seminar: Dr.Vamsi Krishna PAH in connective tissue diseases CTD accounts for 30% of PAH according to US PAH registry. Incidence is on
More informationAcute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema
Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema A.D. Margulescu 1,2, R.C. Sisu 1,2, M. Florescu 2,
More informationLeft Ventricular Diastolic Dysfunction in South Indian Essential Hypertensive Patient
Left Ventricular Diastolic Dysfunction in South Indian Essential Hypertensive Patient Dr. Peersab.M. Pinjar 1, Dr Praveenkumar Devarbahvi 1 and Dr Vasudeva Murthy.C.R 2, Dr.S.S.Bhat 1, Dr.Jayaraj S G 1
More informationSupplementary Online Content
Supplementary Online Content Caglayan E, Axmann S, Hellmich M, Moinzadeh P, Rosenkranz S. Vardenafil for the treatment of Raynaud phenomenon: a randomized, double-blind, placebocontrolled crossover study.
More informationDisease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group
Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group P. Airò, M. Rossi 1, M. Scarsi, E. Danieli, A. Grottolo
More informationTest Name Results Units Bio. Ref. Interval
135091662 Age 45 Years Gender Male 29/8/2017 120000AM 29/8/2017 100215AM 29/8/2017 110825AM Ref By Final RHEUMATOID AUTOIMMUNE COMREHENSIVE ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), SERUM ----- 20-60
More informationClinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China
Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China J. Huang 1, M. Li 1, Z. Tian 2, E. Hsieh 3, Q. Wang 1, Y. Liu 1, D. Xu 1, Y. Hou 1,
More informationAnnual Congress of the European Society of Cardiology Munich, August
Annual Congress of the European Society of Cardiology Munich, August 26 2012 Gas exchange measurements during exercise show early pulmonary arterial hypertension in scleroderma patients Daniel Dumitrescu,
More informationNailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis
Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis C. Kayser, J.Y. Sekiyama, L.C. Próspero, C.Z. Camargo, L.E.C. Andrade Rheumatology Division, Universidade
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/37038 holds various files of this Leiden University dissertation Author: Ninaber, Maarten Title: Pulmonary structure and function analysis in systemic sclerosis
More informationClinical implication of exercise pulmonary hypertension: when should we measure it?
Clinical implication of exercise pulmonary hypertension: when should we measure it? Jang-Young, Kim Wonju College of Medicine, Yonsei Univ. Exercise pulmonary hypertension (EPH) Introduction of pulmonary
More informationSecondary Raynaud s Phenomenon
Secondary Raynaud s Phenomenon Ulf Müller-Ladner University of Giessen Kerckhoff Clinic Bad Nauheim Germany Clinical problems in SSc Therapeutic solutions? Pulmonary fibrosis + PAH Diffuse Pulmonary fibrosis,
More informationSCLERODERMA. Scleroderma update. No disclosures or conflicts. Leslie Kahl, M.D. April 10, 2015
Scleroderma update Leslie Kahl, M.D. April 10, 2015 No disclosures or conflicts KT is a 45 year old woman who developed puffiness in her fingers 1/2013 and carpal tunnel syndrome and arthralgias 3/2013.
More informationDocSpot what patients want to know
DocSpot what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012 Copyright 2011 Raynaud's & Scleroderma Association. Charity Reg. No. 326306 DocSpot Live!
More informationSurvival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases
ARTHRITIS & RHEUMATISM Vol. 60, No. 2, February 2009, pp 569 577 DOI 10.1002/art.24267 2009, American College of Rheumatology Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum
More informationUSEFULNESS OF HRCT IN DIAGNOSIS AND FOLLOW UP OF PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS
USEFULNESS OF HRCT IN DIAGNOSIS AND FOLLOW UP OF PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS Brestas P., Vergadis V., Emmanouil E., Malagari K. 2 nd Dept of Radiology, University of Athens, Greece ABSTRACT
More informationAssessing the Impact on the Right Ventricle
Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal
More informationThomas A. Medsger, Jr., MD University of Pittsburgh School of Medicine. Disclosures: None
Thomas A. Medsger, Jr., MD University of Pittsburgh School of Medicine Disclosures: None 4000+ patients enrolled 1972- present; 5+ visits per patient; 20,000+ patient years of follow- up All clinical and
More informationPulmonary Hypertension. Echocardiography: Pearls & Pitfalls
Pulmonary Hypertension Echocardiography: Pearls & Pitfalls Αθανάσιος Γ. Κουτσάκης Ειδικευόμενος Καρδιολογίας Α Καρδιολογική Κλινική ΑΠΘ Σεμινάρια Ομάδων Εργασίας Ελληνικής Καρδιολογικής Εταιρείας Ιωάννινα,
More informationNon-commercial use only
Reumatismo, 2015; 67 (1): 21-25 Systemic sclerosis sine scleroderma: a of anterior uveitis T. Borges, J. Vilaça, S. Ferreira, I. Chora, S. Silva, C. Dias Internal Medicine Department, Centro Hospitalar
More informationRight Ventricular Strain in Normal Healthy Adult Filipinos: A Retrospective, Cross- Sectional Pilot Study
Right Ventricular Strain in Normal Healthy Adult Filipinos: A Retrospective, Cross- Sectional Pilot Study By Julius Caesar D. de Vera, MD Jonnah Fatima B. Pelat, MD Introduction Right ventricle contributes
More informationPulmonary Arterial Hypertension in systemic sclerosis
Pulmonary Arterial Hypertension in systemic sclerosis From the 3 rd Alpe Adria Meeting on Pulmonary Hypertension - Focus on Scleroderma October 5-6, 2012, Opatija, Croatia by Norbert Hasenoehrl Medical
More informationlinear regression were used to examine relationships between ILD and PH severity
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters A. Fischer 1, J.J. Swigris 1, M.B. Bolster 2,
More informationCombined Pulmonary Fibrosis and Emphysema - A Case Series
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 1 Ver. III (January. 2017), PP 15-19 www.iosrjournals.org Combined Pulmonary Fibrosis and Emphysema
More informationComprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.
Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP North Shore HS, LIJ/Lenox Hill Hospital, New York
More informationPredictors of unfavorable outcome after atrial septal defect closure in adults
after atrial septal defect closure in adults H. M. Gabriel 1, M. Humenberger 1, R. Rosenhek 1, GP. Diller 2, G. Kaleschke 2, TH. Binder 1, P. Probst 1, G. Maurer 1, H. Baumgartner 2 (1) Medical University
More informationDoppler-echocardiographic findings in a patient with persisting right ventricular sinusoids
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 1990 Doppler-echocardiographic findings in a patient with persisting right
More informationCardiothoracic Manifestations of Connective Tissue Disease
Cardiothoracic Manifestations of Connective Tissue Disease Carole Dennie MD FRCPC Professor of Radiology and Medicine Head, Thoracic and Cardiac Imaging Sections The Ottawa Hospital Co-director Cardiac
More information2/4/2011. Nathan Kerner, M.D.
Nathan Kerner, M.D. Definition Elevated pressures - cut off usually >40 mmhg pulmonary artery systolic pressure (PASP) Usually associated with elevated pulmonary vascular resistance (PVR) measured in dynessec/cm
More informationInstructions: This form is completed and entered for all participants. Database will skip over sections that do not apply.
Revision of 08/30/2017 Form #102 Page 1 of 6 PVDOMICS STUDY PVD Assessment - Form #102 Instructions: This form is completed and entered for all participants. Database will skip over sections that do not
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationPulmonary arterial hypertension. Pulmonary arterial hypertension: newer therapies. Definition of PH 12/18/16. WHO Group classification of PH
Pulmonary arterial hypertension Pulmonary arterial hypertension: newer therapies Ramona L. Doyle, MD Clinical Professor of Medicine, UCSF Attending Physician UCSF PH Clinic Definition and classification
More informationClinical Study Pulmonary Arterial Hypertension in Patients with Primary Sjögren s Syndrome
Autoimmune Diseases, Article ID 710401, 5 pages http://dx.doi.org/10.1155/2014/710401 Clinical Study Pulmonary Arterial Hypertension in Patients with Primary Sjögren s Syndrome Senol Kobak, 1 Sezai Kalkan,
More informationRelationship between Peripheral Arterial Stiffness and Estimated Pulmonary Pressure by Echocardiography in Systemic Sclerosis
Original Article Acta Cardiol Sin 2017;33:514 522 doi: 10.6515/ACS20170220A Pulmonary Arterial Hypertension Relationship between Peripheral Arterial Stiffness and Estimated Pulmonary Pressure by Echocardiography
More informationHEMODYNAMIC ASSESSMENT
HEMODYNAMIC ASSESSMENT INTRODUCTION Conventionally hemodynamics were obtained by cardiac catheterization. It is possible to determine the same by echocardiography. Methods M-mode & 2D echo alone can provide
More informationHaving a stem cell transplant for scleroderma a patient and doctor perspective
Having a stem cell transplant for scleroderma a patient and doctor perspective Professor Chris Denton, On behalf of an excellent team across UCLPartners Royal Free Hospital and University College London,
More informationPage 126. Type of Publication: Original Research Paper. Corresponding Author: Dr. Rajesh V., Volume 3 Issue - 4, Page No
ISSN- O: 2458-868X, ISSN P: 2458 8687 Index Copernicus Value: 49. 23 PubMed - National Library of Medicine - ID: 101731606 SJIF Impact Factor: 4.956 International Journal of Medical Science and Innovative
More informationAutoantibodies in the Idiopathic Inflammatory Myopathies
Autoantibodies in the Idiopathic Inflammatory Myopathies Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic Rochester, MN The Myositis Association Annual Conference St. Louis, MO Sept. 25,
More informationScleroderma and PAH Overview. PH Resource Network Martha Kingman, FNP C UTSW Medical Center at Dallas
Scleroderma and PAH Overview PH Resource Network 2007 Martha Kingman, FNP C UTSW Medical Center at Dallas Scleroderma and PAH Outline: Lung involvement in scleroderma Evaluation of the scleroderma patient
More informationAortic stenosis (AS) is common with the aging population.
New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationPulmonary hypertension in clinical practice: are we focusing on the problem?
Pulmonary hypertension in clinical practice: are we focusing on the problem? Odd Bech-Hanssen, MD, PhD Cardiology/Clinical Physiology Sahlgrenska University Hospital Gothenburg, Sweden Definition Mean
More informationPulmonary arterial hypertension (PAH) is
Eur Respir Rev 21; 19: 118, 314 32 DOI: 1.1183/95918.781 CopyrightßERS 21 REVIEW Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease
More informationEchocardiographic Correlates of Pulmonary Artery Systolic Pressure
Echocardiographic Correlates of Pulmonary Artery Systolic Pressure The Role of Left Ventricular Diastolic Function Yoram Agmon MD, Shemy Carasso MD, Diab Mutlak MD, Jonathan Lessick MD Dsc, Izhak Kehat
More informationSclérodermie systémique Hypertension artérielle pulmonaire (excepté la thérapeutique)
DU maladies systémiques 13 octobre 2017 Sclérodermie systémique Hypertension artérielle pulmonaire (excepté la thérapeutique) Luc Mouthon Service de Médecine Interne, hôpital Cochin, Centre de Référence
More informationPrevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature
Clin Rheumatol (2013) 32:1519 1531 DOI 10.1007/s10067-013-2307-2 ORIGINAL ARTICLE Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature
More informationStress Testing in Valvular Disease
2017 ASE Florida Orlando, FL October 10, 2017 2:40 2:50 PM 10 min Grand Harbor Ballroom South Stress Testing in Valvular Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate
More informationPulmonary Hypertension: Follow-up in adolescence and adults
Pulmonary Hypertension: Follow-up in adolescence and adults Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center University of Muenster Germany
More informationImages in Cardiovascular Medicine
Images in Cardiovascular Medicine Management of Severe Mitral Stenosis During Pregnancy Rebecca S. Norrad, MBBS; Omid Salehian, MSc, MD, FRCPC, FACC, FAHA A 37-year-old woman originally from Iraq was referred
More informationExercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation
Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation Julien Magne, PhD, Kim O Connor, MD, Giuseppe Romano, MD, Marie Moonen, MD, Luc A.
More informationΜαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
More informationE LeAP STUDY ECHOCARDIOGRAPHIC LEFT ATRIAL PRESSURE: COMPARATIVE REVIEW IN PATIENTS WITH SINUS RHYTHM AND ATRIAL FIBRILLATION
E LeAP STUDY ECHOCARDIOGRAPHIC LEFT ATRIAL PRESSURE: COMPARATIVE REVIEW IN PATIENTS WITH SINUS RHYTHM AND ATRIAL FIBRILLATION Moghniuddin Mohammed, M.B.B.S. Mentor: Dr. Harry McCrea, M.D. Dr. Yuji Saito,
More information2) VSD & PDA - Dr. Aso
2) VSD & PDA - Dr. Aso Ventricular Septal Defect (VSD) Most common cardiac malformation 25-30 % Types of VSD: According to position perimembranous, inlet, muscular. According to size small, medium, large.
More information